Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.56
-$1.37 (-5.28%)
After-hours:
Nov 5, 2026, 6:19 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -111.46M | -80.99M | -240.44M | -51.5M | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M | -29.05M | -19.1M | -18.99M |
Depreciation & Amortization | 4K | -104K | -29K | 11K | -923K | 23K | 33K | 36K | 35K | 33K | 30K | 26K | 29K | 28K | 25K |
Stock-Based Compensation | 8.62M | 9.2M | 7.58M | 7.34M | 6.05M | 5.39M | 5.5M | 2.84M | 1.54M | 947K | 1.14M | 1M | 669K | 687K | 289K |
Other Working Capital | 10.11M | -11.66M | 7.2M | -1.71M | 17.25M | -11.74M | 3.45M | 1.15M | 5.64M | 3.46M | 4.45M | -3.62M | -866K | -7.58M | 1.52M |
Other Non-Cash Items | 36.82M | 6.56M | 172.16M | 6.69M | 200K | -29K | -344K | 125K | 291K | 853K | 455K | 173K | 10.21M | 191K | 309K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.78M | -9.86M | 8.31M | -3.66M | 5.16M | -8.86M | 8.87M | 4.54M | 5.16M | 6.87M | 7.57M | -4.96M | -2.77M | -7.87M | 1.24M |
Operating Cash Flow | -57.24M | -75.2M | -52.41M | -41.13M | -41.74M | -37.05M | -38.55M | -31.06M | -30.96M | -19.1M | -15.4M | 31.85M | -20.91M | -26.06M | -17.13M |
Capital Expenditures | n/a | -2K | n/a | n/a | n/a | -18K | -74K | n/a | -35K | -22K | -17K | n/a | n/a | n/a | -1.07M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -331.81M | -76.52M | -132.89M | -59.2M | -126.55M | -99.11M | -9.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 74.11M | 108.13M | 69.53M | 104.24M | 14.26M | 12.86M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -30M | n/a | -30M | -5M | n/a | n/a | n/a | -26.76M | n/a | n/a | n/a | n/a | n/a | n/a | -1M |
Investing Cash Flow | -287.7M | 31.61M | -93.36M | 40.04M | -112.29M | -86.27M | -3.74M | -26.76M | -35K | -22K | -17K | n/a | n/a | n/a | -1.07M |
Debt Repayment | 29.1M | 267.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.95M | n/a | -9.34M | 71.68M | n/a | n/a | -4.4M | -439K | -766K | -656K | n/a | n/a | n/a | n/a | 59.39M |
Financial Cash Flow | 42.06M | 433.48M | 140.84M | 72.62M | 1.72M | 99K | 1.85M | 233.98M | 177.74M | -614K | 50K | 20M | 11K | 55K | 59.39M |
Net Cash Flow | -303.65M | 389.58M | -4.92M | 71.56M | -152.55M | -123.28M | -40.3M | 176.11M | 146.78M | -19.7M | -15.45M | 51.85M | -20.74M | -26.01M | 41.21M |
Free Cash Flow | -57.24M | -75.2M | -52.41M | -41.13M | -41.74M | -37.07M | -38.63M | -31.06M | -30.99M | -19.12M | -15.42M | 31.85M | -20.91M | -26.06M | -18.2M |
Adj. Free Cash Flow | -65.86M | -84.39M | -59.99M | -48.46M | -47.79M | -42.46M | -44.12M | -33.9M | -32.53M | -20.07M | -16.55M | 30.84M | -21.58M | -26.75M | -18.49M |
Maintenance CapEx | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | -35K | -22K | -17K | n/a | n/a | n/a | -25K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -18K | -74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.05M |
Owner Earnings | -57.24M | -75.2M | -52.41M | -41.13M | -41.74M | -37.05M | -38.55M | -31.06M | -30.99M | -19.12M | -15.42M | 31.85M | -20.91M | -26.06M | -17.15M |
Add to Watchlist
Select watchlists to add or remove ZBIO